MIGRAINE DISORDERS
Clinical trials for MIGRAINE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new MIGRAINE DISORDERS trials appear
Sign up with your email to follow new studies for MIGRAINE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Migraine prevention drug for kids falls short in early trial
Prevention TerminatedThis study aimed to see if the drug SPN-538 could prevent migraines in children aged 6 to 11. It included 26 children who had migraines for at least 6 months. The study was stopped early, so results are limited.
Matched conditions: MIGRAINE DISORDERS
Phase: PHASE4 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Prevention
Last updated May 11, 2026 20:38 UTC
-
Migraine drug fremanezumab tested for sleep benefits in small study
Symptom relief TerminatedThis study looked at whether fremanezumab, an FDA-approved migraine prevention drug, could also improve sleep quality in people with migraines. Researchers planned to track 22 adults aged 18-65 who had 10-25 headache days per month. The study was terminated early, so results are …
Matched conditions: MIGRAINE DISORDERS
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated May 07, 2026 18:41 UTC